Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.14 | 15.02 |
| PEG Ratio (TTM) | -0.31 | -0.03 |
| P/S Ratio (TTM) | 1.02 | 2.62 |
| P/B Ratio (TTM) | 0.61 | 1.40 |
| P/FCF Ratio (TTM) | 237.27 | 6.39 |
| Price to 5YR AVG Earnings Ratio | 6.64 | 14.54 |
| Price to 5YR AVG FCF Ratio | 4.95 | 8.92 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.51% | 0.95% |
| ROE (TTM) | 5.06% | 9.49% |
| Net Profit Margin (TTM) | 8.40% | 16.54% |
| ROIC 5YR AVG | 15.63% | 16.89% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -50.21% | 25.06% | 19.58% |
| Revenue | 18.18% | 20.33% | 30.46% |
| Net Income | -41.32% | 35.07% | 25.04% |
| Cash Flow | -235.35% | 96.47% | 47.85% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.10 | 12.17 |
| Quick Ratio (TTM) | 0.10 | 12.40 |
| D/E Ratio (TTM) | 0.32 | 1.04 |
| Interest Coverage (TTM) | 0.80 | 0.73 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | N/A | 0.43 |
| LTL to 5YR AVG FCF | 2.61 | 5.69 |
| Shares Outstanding Growth 5YR AVG | 3.01% | 65.24% |